Found 35 matching trials
A Study of Lasmiditan in Healthy Japanese and Caucasian Participants
PHASE1The main purpose of this study is to evaluate the safety and tolerability o...
A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine
PHASE2This study will assess the efficacy and safety of lasmiditan in the acute t...
Location
Takanoko Hospital
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
PHASE3The reason for this study is to see if lasmiditan is safe and effective in ...
Location
Central Research Associates
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
PHASE3The reason for this study is to see how effective and safe the study drug k...
Location
Rehabilitation & Neurological Services LLC
A Study of Lasmiditan in Healthy Participants When Co-administered With Topiramate
PHASE1This study will assess the safety, tolerability and blood concentrations of...
Location
Covance Madison CRU
Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration
PHASE1This study will be an open-label, nonrandomized, absorption, metabolism, an...
Location
Covance Clinical Research Unit
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
PHASE1This is a randomized, double-blind, three-period, cross-over study to inves...
Location
SNBL Clinical Pharmacology Unit
Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
PHASE2The purpose of this study is to evaluate the efficacy and safety of a range...
Location
Multiple Locations
Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function
PHASE1This is a multi-center, open-label, non-randomized, parallel-group, adaptiv...
Location
CIUSSS de l'est-de-l'île-de-Montréal - installation Hôpital Maisonneuve-Rosemont
A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users
PHASE1The purpose of this study is to assess the abuse potential of study drug la...
Location
Vince & Associates Clinical Research, Inc.